Benchmark Downgrades Nephros (NEPH) to Hold
Tweet
Share
E-mailGet Alerts NEPH Hot Sheet
Price: $2.21 -3.49%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 17 | New: 51
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 17 | New: 51
Join SI Premium – FREE
Benchmark analyst Robert Wasserman downgraded Nephros (NASDAQ: NEPH) from Speculative Buy to Hold.
For an analyst ratings summary and ratings history on Nephros click here. For more ratings news on Nephros click here.
Shares of Nephros closed at $2.21 yesterday.
You May Also Be Interested In
- Goldman Sachs Downgrades AIB Group PLC (AIBG:ID) (AIBRF) to Neutral
- Piper Sandler Downgrades Texas Roadhouse (TXRH) to Neutral; 'More Balanced Risk-Reward'
- Jefferies Downgrades Ganfeng Lithium Group Co Ltd (002460:CH) to Underperform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
